Litcius/Paper detail

Mannose-mediated nanodelivery of methotrexate to macrophages augments rheumatoid arthritis therapy

Liang Yang, Yongjie Sha, Yuansong Wei, Hanghang Fang, Jingjing Jiang, Lichen Yin, Zhiyuan Zhong, Fenghua Meng

2023Biomaterials Science22 citationsDOI

Abstract

studies revealed that Man-PMTX showed significantly higher accumulation in inflammatory joints than in healthy joints and effectively treated RA by relieving inflammation, repolarizing macrophages from M1 type to M2 type, and mitigating proinflammatory cytokines. Accordingly, Man-PMTX effectively protected the synovium and bone from damage. Mannose-mediated nanodelivery of methotrexate to macrophages appears to be an attractive strategy to augment rheumatoid arthritis therapy.

Topics & Concepts

MethotrexateRheumatoid arthritisMedicineInflammationMacrophagePharmacologyProinflammatory cytokineImmunologyIn vivoArthritisCancer researchChemistryIn vitroBiologyBiochemistryBiotechnologyAutoimmune and Inflammatory Disorders ResearchRheumatoid Arthritis Research and TherapiesChronic Lymphocytic Leukemia Research
Mannose-mediated nanodelivery of methotrexate to macrophages augments rheumatoid arthritis therapy | Litcius